Kristin Kremer is a senior laboratory scientist with a PhD in molecular epidemiology of tuberculosis (TB). She joined KNCV in October 2020 to support KNCV’s work on antimicrobial drug resistance (AMR), diagnostics and laboratory networks.

Previously, Kristin coordinated the Bacteriological Serology Diagnostics Unit at the National Institute for Public Health (RIVM) in the Netherlands. At WHO/Europe, Kristin coordinated the TB laboratory network, the organization of drug resistance surveys, and the implementation of new diagnostics for TB in the WHO European Region. She supported the establishment of the European TB Laboratory Initiative, the first Structured Operational Research and Training Initiative (SORT-IT) in Eastern Europe, and workshops on the molecular diagnosis of TB and surveillance of drug resistance. At the national TB reference laboratory at the RIVM, Kristin managed EU projects on the molecular epidemiology of TB and the surveillance of MDR-TB in Europe. She was the principal investigator of an EU project studying the effect of genetic variation of M. tuberculosis on vaccine escape and drug resistance. Furthermore, she was involved in studies on the phylogeny and evolution of M. tuberculosis complex. Kristin has over 165 publications in peer reviewed journals and contributed to various WHO publications.